title: Development of a fluoridated, daily-use toothpaste containing NovaMin technology for the treatment of dentin hypersensitivity.
authors: GlaxoSmithKline Consumer Healthcare Weybridge, Surrey, UK. Teresa.M.Layer@gsk.com
authors: Teresa May
authors: TM
authors: Layer
mesh_terms: D002130:Calcium Phosphates / Q000494:pharmacology / Q000627:therapeutic use; D002327:Cariostatic Agents / Q000494:pharmacology / Q000627:therapeutic use; D003804:Dentin / Q000187:drug effects; D057133:Dentin Desensitizing Agents / Q000494:pharmacology / Q000627:therapeutic use*; D003807:Dentin Sensitivity / Q000188:drug therapy*; D005459:Fluorides / Q000627:therapeutic use*; D005898:Glass; D006801:Humans; D017640:Silicates / Q000627:therapeutic use; D014089:Tooth Remineralization / Q000379:methods; D014100:Toothpastes / Q000138:chemical synthesis / Q000627:therapeutic use*
chemical_list: D002130:Calcium Phosphates; D002327:Cariostatic Agents; D057133:Dentin Desensitizing Agents; C510984:NovaMin; D017640:Silicates; D014100:Toothpastes; C076375:rhenanite; D005459:Fluorides